Panagora Asset Management Inc Pacira Bio Sciences, Inc. Transaction History

Panagora Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$59.18 - $69.99 $782,655 - $925,617	-13,225 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$59.31 - $78.82 $2.58 Million - $3.42 Million	-43,442 Reduced 76.66%	13,225 $927,000
Q4 2020 Feb 10, 2021	BUY	$50.47 - $66.26 $608,213 - $798,499	12,051 Added 27.01%	56,667 $3.39 Million
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $1.68 Million - $2.04 Million	-32,328 Reduced 42.01%	44,616 $2.68 Million
Q2 2019 Aug 09, 2019	SELL	$36.57 - $47.97 $934,144 - $1.23 Million	-25,544 Reduced 24.92%	76,944 $3.35 Million
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $3.13 Million - $3.62 Million	85,787 Added 513.66%	102,488 $3.9 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $689,918 - $871,124	16,701 New	16,701 $718,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $946M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.